Arrowhead Pharmaceuticals, Inc. (ARWR) PT Lowered to $75 at Jefferies, Following Model Update Ahead Of Earnings
Tweet Send to a Friend
Jefferies analyst Maury Raycroft lowered ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
